Thomas C. Quinn, M.D., M.Sc.

Thomas C. Quinn, M.D., M.Sc.
Thomas C. Quinn, M.D., M.Sc., is the associate director for international research and the senior investigator in the laboratory of immunoregulation at the National Institute of Allergy and Infectious Diseases. Since 1981, he has been assigned to The Johns Hopkins University School of Medicine where he is a professor of medicine and pathology, and has adjunct appointments in the Departments of International Health, Epidemiology, and Molecular Microbiology and Immunology in The Johns Hopkins Bloomberg School of Public Health. In 2006, he became the inaugural director of the Johns Hopkins Center for Global Health, coordinating all international research at the allied medical institutions of Johns Hopkins University. He also directs the Johns Hopkins School of Medicine P3 HIV/AIDS Research Facility and the International STD/HIV Research Laboratory. He is board certified in internal medicine and in infectious diseases and is on the clinical staff of Johns Hopkins Hospital and the NIH Clinical Center.

Dr. Quinn's investigations have involved the study of the epidemiologic, virologic and immunologic features of HIV infection in Africa, the Caribbean, South America and Asia. In 1983, he led the first group of scientists to Haiti and central Africa to determine the extent of HIV within those countries. In 1984, he helped establish the interagency project called "Projet SIDA" in Kinshasa, Zaire, which was the largest AIDS investigative project in sub-Saharan Africa. Since then he has generated numerous global initiatives and research programs in 28 countries. He was among the first to describe the heterosexual transmission of HIV in Haiti, Zaire, Kenya, India, and more recently, China. He demonstrated that HIV viral load was the single most important predictor of HIV perinatal and sexual transmission, correlating this with timing of infection and natural history. More recent collaborative studies in Uganda have also provided evidence that male circumcision can reduce HIV acquisition by at least 50%.

Dr. Quinn is a member of the Institute of Medicine of the National Academy of Science. He is a fellow of the Infectious Disease Society of America, a member of the American Association of Physicians, and a member of the American Society for Clinical Investigation. He is an advisor/consultant on HIV and STDs to the WHO, PAHO, UNAIDS and FDA. He served on the Board of Directors for the Infectious Diseases Society of America and the National Foundation for Infectious Diseases. He is a founding member of the Academic Alliance for AIDS Care and Prevention in Africa and helped design the Infectious Diseases Institute of Makerere University School of Medicine where he also holds an adjunct appointment in medicine. He is the recipient of multiple awards and honors and is an author of more than 700 publications on HIV, STDs and infectious diseases.

Disclosures

Dr. Quinn reports that he has no significant relationships to disclose.

.